Search

Search Constraints

You searched for: Author/Creator Michalova, Kyra

Search Results

1. Alternating R‐CHOP and R‐cytarabine is a safe and effective regimen for transplant‐ineligible patients with a newly diagnosed mantle cell lymphoma. Issue 1 (30th October 2017)

2. Characterization of chromosome 11 breakpoints and the areas of deletion and amplification in patients with newly diagnosed acute myeloid leukemia. Issue 7 (12th April 2013)

3. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes. (March 2016)

4. Cryptic aberrations may allow more accurate prognostic classification of patients with myelodysplastic syndromes and clonal evolution. Issue 7 (25th March 2020)

5. Fusion of the additional sex combs like 1 and teashirt zinc finger homeobox 2 genes resulting from ider(20q) aberration in a patient with myelodysplastic syndrome. (10th October 2013)

6. Genetic and epigenetic characterization of low‐grade gliomas reveals frequent methylation of the MLH3 gene. Issue 11 (25th August 2015)

7. Genome‐wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide. (11th November 2014)

8. High frequency of dicentric chromosomes detected by multi-centromeric FISH in patients with acute myeloid leukemia and complex karyotype. (May 2018)

9. High level of full‐length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide. (31st October 2014)

10. Lenalidomide treatment in lower risk myelodysplastic syndromes—The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients). (June 2018)